Please login to the form below
Nuplazid
This page shows the latest Nuplazid news and features for those working in and with pharma, biotech and healthcare.
Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug
Some atypical antipsychotic medicines are used to treat more advanced cases of PDP but - unlike Nuplazid - run the risk of aggravating motor symptoms. ... The company is also working on follow-up indications for Nuplazid, including clinical programmes in
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Srdjan Stankovic joins Acadia Pharmaceuticals
efforts to explore the full potential of Nuplazid to treat patients suffering from additional CNS disorders.” . ... I look forward to leading the team in advancing the promising development programmes with Nuplazid.".
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Global Business Development Director – Health Education
-
excellent commission
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
-
Account Manager / Account Director
-
Competative
-
Associate Director
-
£75, 000-90, 000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- Immunomedics craters after FDA rejects breast cancer ADC
- NHS England sees off AbbVie's Hep C legal challenge
- J&J’s Erleada cleared for early prostate cancer in Europe
- Unlocking the potential of science and technology in the UK
- A Magical Future – A year on from the graduate scheme
- Rising economic risk casts shadow on Davos meeting
- Vertex gains EU approval for earlier Orkambi use
- Neoantigen player Achilles gets OK for first clinical trial
- Star Europe kicks off 2019 in style
PMHub
Dovetail
About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...
Latest intelligence
- Unlocking the potential of science and technology in the UK
- Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
Quick links
Infographics
